Our focus is investing in companies
in the lower and middle markets that
have developed new technologies
products and services which when
grown organically and merged with
complimentary business entities can
be grown rapidly to increase global
market share and financially realise
the potential of the combined entities
Investment Focus
The 393 Private Equity Team identify, invest in and grow entities that have developed new, or enhanced existing technology, products and services and have reached a point where they need a hands on business partner to invest in their business.
393 will invest in companies financially and organisationally so the leadership team can focus on sales, marketing, recruitment brand and technology to ensure rapid future growth is achieved through acquisitions and organically, in the following markets:
Manufacturing
- Defence Manufacturing and Supplies
- Pharmaceutical & Chemical Processing
- Medical Device Manufacturing
- Life Sciences Biotechnology Devices
Software Applications and Platforms
- Defence, Pharmaceutical and Medical Platforms
- Artificial Intelligence
- Integrated Risk, Compliance, Certification Software
Life Essentials (Food, Water, Health, Shelter)
- Food Supply Chain
- Water Treatment Technology
- Human Drug Development
- Antimicrobial Resistance (MRSA, VRE, MDR-TB)
- Real Estate
AGRISCIENTIFIC specialises in Agribusiness, categories include: Agriculture, Livestock, Fisheries, Food Processing & Distribution,
Forestry, Biofuel and Biotechnology.
At the current rate of global population growth and the predicted increase in crop destruction due to environment stress from global warming and pathogens, every country in the World however rich or poor, will be impacted by food shortages rationing and starvation by 2050
GENETIC ENGINEERING TECHNOLOGY (SEEDS, TUBERS)
we will invest in companies who use genetic engineering to develop genetically edited seeds, tubers and grain to solve
the crop destruction challenges farmers face with drought, floods and salinity
GENETIC ENGINEERING TECHNOLOGY (LIVESTOCK)
we will invest in companies who specialise in animal genetics
AQUACULTURE we will invest in Aquaculture also known as Aquafarming which is the farming of aquatic plants, algae, fish, crustaceans, mollusks and other organisms involving cultivating freshwater & saltwater populations under controlled conditions. We are currently investigating processes for bioengineering the accelerated growth rate of enriched nutritional content seaweed, so it can be used as low cost, high nutrition, mineral rich livestock feed.
Transaction Types
We invest across three types of scenarios that are consistent with our investment criteria
Divestitures / Carve-Out’s
The acquisition of highly integrated business divisions on complex global shared services manufacturing ERP platforms like SAP, that are very challenging and difficult to carve out and and transition to being fully operationally stand alone self supporting legal entities quickly. And the acquisition of standalone entities considered non core by its corporate or private equity parent.
Venture Capital Investment / Growth Capital
We will invest in companies that need financial capital to grow their businesses by developing and taking new products to market. We are currently working with pioneering leaders in scientific research who will use our investment strategies to provide them with the financial and commercial support they need to deliver their world changing products globally.
Distressed Investing / Turnarounds
Investing in or acquiring companies that are underperforming or in short term financial distress, to stabilise them financially and operationally and once profitable merging selling them or merging them with similar companies in our portfolio who are in the same market space or industry.
